Abstract:Aptamers, also known as chemical antibodies, are short single-stranded DNA, RNA or peptide molecules. These molecules can fold into complex three-dimensional structures and bind to target molecules with high affinity and specificity. The nucleic acid aptamers are selected from combinatorial libraries by an iterative in vitro selection procedure known as systematic evolution of ligands by exponential enrichment (SELEX). As a new class of therapeutics and drug targeting entities, bivalent and multivalent aptamer-based molecules are emerging as highly attractive alternatives to monoclonal antibodies as targeted therapeutics. Aptamers have several advantages, offering the possibility of overcoming limitations of antibodies: 1) they can be selected against toxic or non-immunogenic targets; 2) aptamers can be chemically modified by using modified nucleotides to enhance their stability in biological fluids or via incorporating reporter molecules, radioisotopes and functional groups for their detection and immobilization; 3) they have very low immunogenicity; 4) they display high stability at room temperature, in extreme pH, or solvent; 5) once selected, they can be chemically synthesized free from cell-culture- derived contaminants, and they can be manufactured at any time, in large amounts, at relatively low cost and reproducibly; 6) they are smaller and thus can diffuse more rapidly into tissues and organs, leading to faster targeting in drug delivery; 7) they have lower molecular weight that can lead to faster body clearance, resulting in a low background noise for imaging and minimizing the radiation dose to the patient in diagnostic imaging. Thus, the high selectivity and sensitivity, ease of screening and production, chemical versatility as well as stability make aptamers a class of highly attractive agents for the development of novel therapeutics, targeted drug delivery vehicles and molecular imaging. In the review, we will discuss the latest technological advances in developing aptamers, its application as a novel class of drug on its own, as well as in surface functionalization of both polymer nanoparticles or nanoliposomes in the treatment of cancer, viral and autoimmune diseases.

Advance in Research of Aptamers and Related Drugs

Aptamers: an Emerging Navigation Tool of Therapeutic Agents for Targeted Cancer Therapy

Novel Insights into the Role of Aptamers in the Fight Against Cancer.

Recent Progress In Aptamer Discoveries And Modifications For Therapeutic Applications

Aptamers: Promising Reagents in Biomedicine Application

Aptamer Therapeutics: The 21st Century`s Magic Bullet of Nanomedicine

Oligonucleotide aptamers: Recent advances in their screening, molecular conformation and therapeutic applications

Recent Advances in Aptamer Discovery and Applications

Advances In The Development Of Aptamer Drug Conjugates For Targeted Drug Delivery

Advance in Aptamer Research

Advances in the Development of Aptamer Drug Conjugates for Targeted Drug Delivery.

Nucleic acid aptamers in cancer research, diagnosis and therapy.

Molecular Aptamers for Drug Delivery

Recent Progress and Opportunities for Nucleic Acid Aptamers

Aptamer and Related Progress

Peptide Aptamers with Biological and Therapeutic Applications

Aptamers as Versatile Ligands for Biomedical and Pharmaceutical Applications

Aptamers in cancer therapy: problems and new breakthroughs

Gene therapy progress and prospects: RNA aptamers

Application of Aptamers in Biomedicine

Apatmer Based Analytics Of Biochemicals And Pharmaceuticals